WallStreetZenWallStreetZen

NYSE: RAD
Rite Aid Corp Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for RAD

Based on 2 analysts offering 12 month price targets for Rite Aid Corp.
Min Forecast
$3.00-40.83%
Avg Forecast
$3.75-26.04%
Max Forecast
$4.50-11.24%

Should I buy or sell RAD stock?

Based on 2 analysts offering ratings for Rite Aid Corp.
Strong Sell
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
1 analysts 50%
Strong Sell
1 analysts 50%

Be the first to know when Wall Street analysts revise their RAD stock forecasts and price targets.

RAD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Deutsche Bank
Top 12%
89
Strong SellMaintains$3.00-40.83%2022-10-03
Evercore ISI Group
Bottom 9%
9
SellMaintains$4.50-11.24%2022-09-30

1 of 1

Forecast return on equity

Is RAD forecast to generate an efficient return?

Forecast return on assets

Is RAD forecast to generate an efficient return on assets?
Company
-1.04%
Industry
4.57%
RAD is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

RAD earnings per share forecast

What is RAD's earnings per share in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$0.91
Avg 2 year Forecast
-$1.54

RAD revenue forecast

What is RAD's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$23.8B-1.89%
Avg 2 year Forecast
$23.4B-3.36%
RAD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

RAD revenue growth forecast

How is RAD forecast to perform vs Pharmaceutical Retailers companies and vs the US market?
Company
-1.69%
Industry
1.58%
Market
6.46%
RAD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
RAD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

RAD vs Pharmaceutical Retailer Stocks

TickerPricePrice TargetUp/downsideConsensus
RAD$5.07$3.75-26.04%Strong Sell
YI$2.99$16.00+435.12%Strong Buy
PETS$19.80$25.00+26.26%Hold
HITI$1.86$4.45+139.25%Hold
LFMD$2.43$8.00+229.22%Strong Buy

Rite Aid Stock Forecast FAQ

Is Rite Aid Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NYSE: RAD) stock is to Strong Sell RAD stock.

Out of 2 analysts, 0 (0%) are recommending RAD as a Strong Buy, 0 (0%) are recommending RAD as a Buy, 0 (0%) are recommending RAD as a Hold, 1 (50%) are recommending RAD as a Sell, and 1 (50%) are recommending RAD as a Strong Sell.

If you're new to stock investing, here's how to buy Rite Aid stock.

What is RAD's earnings growth forecast for 2023-2024?

(NYSE: RAD) Rite Aid's forecast annual earnings growth rate of N/A is not forecast to beat the US Pharmaceutical Retailers industry's average forecast earnings growth rate of -2.44%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 19.59%.

Rite Aid's earnings in 2022 is -$866,601,000.On average, 1 Wall Street analyst forecast RAD's earnings for 2023 to be -$51,447,259, with the lowest RAD earnings forecast at -$51,447,259, and the highest RAD earnings forecast at -$51,447,259.

In 2024, RAD is forecast to generate -$87,064,591 in earnings, with the lowest earnings forecast at -$173,563,828 and the highest earnings forecast at -$1,130,709.

What is RAD's revenue growth forecast for 2023-2024?

(NYSE: RAD) Rite Aid's forecast annual revenue growth rate of -1.69% is not forecast to beat the US Pharmaceutical Retailers industry's average forecast revenue growth rate of 1.58%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 6.46%.

Rite Aid's revenue in 2022 is $24,209,922,000.On average, 1 Wall Street analysts forecast RAD's revenue for 2023 to be $1,342,907,438,213, with the lowest RAD revenue forecast at $1,342,907,438,213, and the highest RAD revenue forecast at $1,342,907,438,213.

In 2024, RAD is forecast to generate $1,322,752,833,322 in revenue, with the lowest revenue forecast at $1,319,544,729,268 and the highest revenue forecast at $1,325,960,937,375.

What is RAD's forecast return on assets (ROA) for 2023-2024?

(NYSE: RAD) forecast ROA is -1.04%, which is lower than the forecast US Pharmaceutical Retailers industry average of 4.57%.

What is RAD's Price Target?

According to 2 Wall Street analysts that have issued a 1 year RAD price target, the average RAD price target is $3.75, with the highest RAD stock price forecast at $4.50 and the lowest RAD stock price forecast at $3.00.

On average, Wall Street analysts predict that Rite Aid's share price could fall to $3.75 by Oct 3, 2023. The average Rite Aid stock price prediction forecasts a potential downside of 26.04% from the current RAD share price of $5.07.

What is RAD's Earnings Per Share (EPS) forecast for 2023-2024?

(NYSE: RAD) Rite Aid's current Earnings Per Share (EPS) is -$15.96. On average, analysts forecast that RAD's EPS will be -$0.91 for 2023, with the lowest EPS forecast at -$0.91, and the highest EPS forecast at -$0.91. In 2024, RAD's EPS is forecast to hit -$1.54 (min: -$3.07, max: -$0.02).

What is RAD's forecast return on equity (ROE) for 2023-2024?

(NYSE: RAD) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.